Sweden: Medivir appoints Magnus Christensen as interim CEO

Magnus Christensen, interim CEO, Medivir

Developer of drugs with a focus on cancer, Medivir, has named the company’s CFO, Magnus Christensen, as the interim CEO. He will take up his new role in connection with Medivir’s AGM Meeting on May 5, 2021. He will retain his role as CFO. He replaces Yilmaz Mahshid, who leaves the CEO position at the…

You must be a HMI Subscriber to view this content.

Subscribe Now »